drugset / Trial / NCT04972539
Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults
RandomizedCrossoverOpen-labelTreatment
Summary
To evaluate the safety and pharmacokinetic characteristics of AJU-A51 in healthy adults
Timeline
- Start
- 2020-08-01
- Primary completion
- 2020-11-30
- Completion
- 2021-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AJU-A51 | Unknown | 5 mg | Oral |
| Subject | AJU-A51 | Unknown | 10 mg | Oral |
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Linagliptin | Small molecule | 5 mg | Oral |